Market Cap : 2.88 B | Enterprise Value : 2.44 B | PE Ratio : 28.89 | PB Ratio : 5.94 |
---|
NAS:CORT has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NAS:CORT has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Corcept Therapeutics's enterprise value is $2,441.9 Mil. Corcept Therapeutics's Revenue for the trailing twelve months (TTM) ended in Dec. 2020 was $353.9 Mil. Therefore, Corcept Therapeutics's EV-to-Revenue for today is 6.90.
During the past 13 years, the highest EV-to-Revenue of Corcept Therapeutics was 414.90. The lowest was 2.80. And the median was 11.45.
The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.
EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.
As of today (2021-03-06), Corcept Therapeutics's stock price is $24.550000. Corcept Therapeutics's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2020 was $2.85. Therefore, Corcept Therapeutics's PS Ratio for today is 8.61.
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
* The bar in red indicates where Corcept Therapeutics's EV-to-Revenue falls into.
EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.
Corcept Therapeutics's EV-to-Revenue for today is calculated as:
EV-to-Revenue | = | Enterprise Value (Today) | / | Revenue (TTM) |
= | 2441.873 | / | 353.874 | |
= | 6.90 |
Corcept Therapeutics's current Enterprise Value is $2,441.9 Mil.
Corcept Therapeutics's Revenue for the trailing twelve months (TTM) ended in Dec. 2020 was 93.247 (Mar. 2020 ) + 88.565 (Jun. 2020 ) + 86.327 (Sep. 2020 ) + 85.735 (Dec. 2020 ) = $353.9 Mil.
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.
Corcept Therapeutics's PS Ratiofor today is calculated as:
PS Ratio | = | Share Price (Today) | / | Revenue per Share (TTM) |
= | 24.550000 | / | 2.852 | |
= | 8.61 |
Corcept Therapeutics's share price for today is $24.550000.
Corcept Therapeutics's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2020 was 0.763 (Mar. 2020 ) + 0.719 (Jun. 2020 ) + 0.694 (Sep. 2020 ) + 0.676 (Dec. 2020 ) = $2.85.
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
No Headline